Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Gardner

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
The Journal of Urology|May 4, 2013
Editorial commentThomas A Gardner
The Journal of Urology|June 16, 2009
Prognostic implications of polymorphisms and interleukin-2 therapy for renal cell carcinomaThomas A Gardner, Theodore Logan
Clinical Genitourinary Cancer|January 24, 2006
Prostate cancer therapy with high-intensity focused ultrasoundThomas A Gardner, Michael O Koch
Urology|November 30, 2014
Editorial commentNick W Liu, Thomas A Gardner
Current Treatment Options in Oncology|August 19, 2005
Thermal-based treatment options for localized prostate cancerMichael O Koch, Thomas A Gardner
Urology|February 25, 2014
Editorial commentNick W Liu, Thomas A Gardner
Urology|December 12, 2018
EDITORIAL COMMENTPatrick A Huddleston, Thomas A Gardner
Human Vaccines & Immunotherapeutics|July 27, 2012
Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancerThomas A Gardner, Bennett D Elzey, Noah M Hahn
Journal of Endourology|April 13, 2010
Role of the laparoscopic approach to cytoreductive nephrectomy in metastatic renal-cell carcinoma: does size matter?Anjana Ganeshappa, Chandru Sundaram, Michelle A Lerner, et al.
The Urologic Clinics of North America|April 25, 2006
Future innovations in treating advanced prostate cancerPratik Desai, Juan A Jiménez, Chinghai Kao, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Urology|May 4, 2013
Editorial commentThomas A Gardner
The Journal of Urology|June 16, 2009
Prognostic implications of polymorphisms and interleukin-2 therapy for renal cell carcinomaThomas A Gardner, Theodore Logan
Clinical Genitourinary Cancer|January 24, 2006
Prostate cancer therapy with high-intensity focused ultrasoundThomas A Gardner, Michael O Koch
Urology|November 30, 2014
Editorial commentNick W Liu, Thomas A Gardner
Current Treatment Options in Oncology|August 19, 2005
Thermal-based treatment options for localized prostate cancerMichael O Koch, Thomas A Gardner
Urology|February 25, 2014
Editorial commentNick W Liu, Thomas A Gardner
Urology|December 12, 2018
EDITORIAL COMMENTPatrick A Huddleston, Thomas A Gardner
Human Vaccines & Immunotherapeutics|July 27, 2012
Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancerThomas A Gardner, Bennett D Elzey, Noah M Hahn
Journal of Endourology|April 13, 2010
Role of the laparoscopic approach to cytoreductive nephrectomy in metastatic renal-cell carcinoma: does size matter?Anjana Ganeshappa, Chandru Sundaram, Michelle A Lerner, et al.
The Urologic Clinics of North America|April 25, 2006
Future innovations in treating advanced prostate cancerPratik Desai, Juan A Jiménez, Chinghai Kao, et al.
Pageof 8